# DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations

> **NCT06833814** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Andréanne Côté** · enrollment: 36 (estimated)

## Conditions studied

- Asthma Exacerbations

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT06833814
- **Lead sponsor:** Andréanne Côté
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-17
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06833814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06833814, "DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06833814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*